ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Significant Decline in Short Interest

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 13,400 shares, a decrease of 30.6% from the March 31st total of 19,300 shares. Based on an average daily trading volume, of 20,000 shares, the short-interest ratio is presently 0.7 days.

ProShares UltraShort Nasdaq Biotechnology Stock Performance

Shares of BIS traded down $0.70 on Monday, hitting $19.54. 7,612 shares of the stock traded hands, compared to its average volume of 20,301. The stock’s 50 day moving average is $18.40 and its two-hundred day moving average is $19.98. ProShares UltraShort Nasdaq Biotechnology has a 1 year low of $16.37 and a 1 year high of $26.51.

ProShares UltraShort Nasdaq Biotechnology Announces Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, March 27th. Investors of record on Thursday, March 21st were paid a dividend of $0.1586 per share. The ex-dividend date of this dividend was Wednesday, March 20th.

Hedge Funds Weigh In On ProShares UltraShort Nasdaq Biotechnology

A hedge fund recently bought a new stake in ProShares UltraShort Nasdaq Biotechnology stock. IMC Chicago LLC acquired a new stake in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 15,001 shares of the company’s stock, valued at approximately $271,000. IMC Chicago LLC owned about 3.19% of ProShares UltraShort Nasdaq Biotechnology at the end of the most recent reporting period.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.